D
Sell
8/15/2024Upgraded
Belite Bio, Inc (BLTE) was upgraded to D from E+ on 8/15/2024 due to a substantial increase in the total return index, efficiency index and solvency index. Total capital increased 63.89% from $55.72M to $91.32M.
E
Sell
8/10/2023Downgrade
Belite Bio, Inc (BLTE) was downgraded to E+ from D- on 8/10/2023 due to a decline in the total return index, volatility index and valuation index.
D
Sell
7/26/2023Upgraded
Belite Bio, Inc (BLTE) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
5/31/2023Downgrade
Belite Bio, Inc (BLTE) was downgraded to E+ from D- on 5/31/2023 due to a large decline in the total return index, volatility index and valuation index.
D
Sell
1/4/2023Upgraded
Belite Bio, Inc (BLTE) was upgraded to D- from E+ on 1/4/2023 due to an increase in the valuation index.
E
Sell
10/3/2022Upgraded
Belite Bio, Inc (BLTE) was upgraded to E+ from E on 10/3/2022 due to a significant increase in the total return index and valuation index.
E
Sell
7/26/2022None
Belite Bio, Inc (BLTE) was downgraded to E from U on 07/26/2022.
